Featured,Shroom News Stephen Hurst Steps Down From MindMed’s Board of Directors By Dennis Mutua January 10, 2022 Biotechnology company developing and deploying psychedelic inspired medicines to treat addiction and mental conditions MindMed Inc. (NASDAQ: MNMD) (NEO: MMED) announced Stephen Hurst has resigned from his position as a director to...
Spotlight Stock,Trends & Articles Levitee Labs Announces Formation of Medical Advisory Board By Dennis Mutua January 07, 2022 Multidisciplinary wellness company focused on redefining traditional mental health and addiction treatments through novel psychedelics therapies Levitee Labs Inc. (CSE: LVT) (OTCMKTS: LVTTF) has announced formation of a Medical Ad...
Psychedelic Stocks Washington Psilocybin Bill Would Legalize Supported Adult Use By Dennis Mutua January 06, 2022 This article was first published yesterday on Harvard Law School’s Petrie-Flom Center Bill of Health Blog. On Tuesday, Washington State legislators filed SB 5660, a bill that would legalize the supported adult use of psilocyb...
Spotlight Stock,Trends & Articles McQuade Center for Strategic Research Partners With Mindset Pharma to Develop Psychedelics Medicines By Dennis Mutua January 06, 2022 Biotechnology company focusing on discovering and developing next-generation psychedelic medicines Mindset Pharma Inc. (CSE: MSET) (OTCQB: MSSTF) has entered into a partnership with The McQuade Center for Strategic Research and De...
Psychedelic Stocks The Evolution of Oregon Psilocybin Laws By Dennis Mutua January 05, 2022 Oregon’s Measure 109 allows for the manufacture, delivery, and administration of psilocybin, the compound found in “magic mushrooms.” But how was psilocybin made illegal in the first place? Originally, psilocybin was illegal...
Psychedelic Stocks,Shroom News MindMed Announces Completion of Phase 1 Clinical Trial of 18-MC By Dennis Mutua January 05, 2022 Psychedelic medicine company focusing on discovering, developing and deploying psychedelic-inspired medicine to cure addiction and mental illnesses MindMed Inc. (NASDAQ: MNMD) (NEO: MMED) announced having successfully completed ph...
Psychedelic Stocks Oregon Psilocybin: Licensing Subcommittee Update By Dennis Mutua January 04, 2022 Time for an Oregon psilocybin licensing discussion update. Ballot Measure 109 gave the Oregon Health Authority (“OHA”) two years to create regulations for the manufacturing, testing, sale, and supervised administration of psil...
Spotlight Stock,Trends & Articles Delic CEO Joins Shares His Views on Evolution of Psychedelics Industry in a Podcast By Dennis Mutua January 04, 2022 Matt Stang, the chief executive officer of psychedelic wellness company focusing on bringing safe, legal and science-backed benefits to all Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) joined the Gamechangers Live podcast where...